NR1H4 and metabolic dysfunction-associated steatotic liver disease: Furthermore, the hepatic expression of farnesoid X receptor (FXR) was reduced in both animal models and NAFLD patients, where hepatic FXR expression was reduced in nonalcoholic steatohepatitis (NASH) (Yang et al., 2010).